Professional paper - Letter to the editor
Chronic kidney disease and thrombotic risk in patients with chronic myeloproliferative neoplasms
Journal of Thrombosis and Thrombolysis, 55 (2023), 4; 760-761. https://doi.org/10.1007/s11239-023-02779-w

Lucijanic, Marko; Krečak, Ivan

Cite this document

Lucijanic, M. & Krečak, I. (2023). Chronic kidney disease and thrombotic risk in patients with chronic myeloproliferative neoplasms. Journal of Thrombosis and Thrombolysis, 55. (4), 760-761. doi: 10.1007/s11239-023-02779-w

Lucijanic, Marko and Ivan Krečak. "Chronic kidney disease and thrombotic risk in patients with chronic myeloproliferative neoplasms." Journal of Thrombosis and Thrombolysis, vol. 55, no. 4, 2023, pp. 760-761. https://doi.org/10.1007/s11239-023-02779-w

Lucijanic, Marko and Ivan Krečak. "Chronic kidney disease and thrombotic risk in patients with chronic myeloproliferative neoplasms." Journal of Thrombosis and Thrombolysis 55, no. 4 (2023): 760-761. https://doi.org/10.1007/s11239-023-02779-w

Lucijanic, M. and Krečak, I. (2023) 'Chronic kidney disease and thrombotic risk in patients with chronic myeloproliferative neoplasms', Journal of Thrombosis and Thrombolysis, 55(4), pp. 760-761. doi: 10.1007/s11239-023-02779-w

Lucijanic M, Krečak I. Chronic kidney disease and thrombotic risk in patients with chronic myeloproliferative neoplasms. Journal of Thrombosis and Thrombolysis [Internet]. 2023 February 06 [cited 2024 September 30];55(4):760-761. doi: 10.1007/s11239-023-02779-w

M. Lucijanic and I. Krečak, "Chronic kidney disease and thrombotic risk in patients with chronic myeloproliferative neoplasms", Journal of Thrombosis and Thrombolysis, vol. 55, no. 4, pp. 760-761, February 2023. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:184:890614. [Accessed: 30 September 2024]

Please login to the repository to save this object to your list.